A Quebec woman is the first Canadian to develop a blood clot after receiving the AstraZeneca shot.

The Quebec health ministry says the woman, whose age is not known, received the appropriate care and is recovering at home.

She got the vaccine, made at the Serum Institute of India (SII), that goes by the name Covishield.

Health Canada’s asked AstraZeneca for a full risk assessment of its vaccine after reports of similar costs in Europe, but says the side effect is extremely rare and that the vaccine’s benefits still outweigh its risks.

Over 700,000 doses of the vaccine have been given to Canadians.

Meanwhile, Health Canada says it’s investigating reports of blood clots linked to the Johnson & Johnson vaccine in the U.S.

American regulators are recommending its use be paused after six women developed blood clots and one of them died.

Nearly 7-million Americans have received the J & J vaccine, which has been approved for use in Canada but is not yet available.